Announcements Trials
Browse Landscape

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Interventions

tremelimumab 1durvalumab 1atezolizumab 1Therapeutics 1Immunotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Unresectable Hepatocellular Carcinoma × Clear all
NCT06117891 2026-05-12

REFINE-IO

Bayer

Active not recruiting
300 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT07298538 2025-12-23

Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer

Tianjin Medical University Cancer Institute and Hospital

Active not recruiting
800 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT05660213 2025-05-20

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Fudan University

Not yet recruiting
750 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡